
==== Front
BMC Pregnancy Childbirth
BMC Pregnancy Childbirth
BMC Pregnancy and Childbirth
1471-2393
BioMed Central London

39294589
6818
10.1186/s12884-024-06818-z
Research
Molecular cytogenetic characterization of isolated recurrent 4q35.2 microduplication in Chinese population: a seven-year single-center retrospective study
Zhuang Jianlong 415913261@qq.com

1
Wei Qiulan 2
Jiang Yuying 1
Zeng Shuhong 1
Lou Haijuan 3
Zhang Na zn0402003@163.com

1
Chen Chunnuan chenchunnuan1983@aliyun.com

4
1 Prenatal diagnosis center, Quanzhou Women’s and Children’s Hospital, Quanzhou, 362000 Fujian Province China
2 https://ror.org/04n6gdq39 grid.459785.2 Medical laboratory department, The First People’s Hospital of Nanning, Nanning, 530022 China
3 Be creative Lab Co., Ltd, Beijing, 101100 China
4 https://ror.org/03wnxd135 grid.488542.7 0000 0004 1758 0435 Department of Neurology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000 Fujian Province China
18 9 2024
18 9 2024
2024
24 6069 2 2024
10 9 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Background

With the extensive use of chromosomal microarray analysis (CMA), an increasing number of variants of uncertain significance (VOUS) have been detected. The objective of the present study was to elucidate the pathogenicity and clinical variability associated with isolated recurrent 4q35.2 microduplications within the Chinese population.

Methods

The present study involved 14 cases of isolated recurrent 4q35.2 microduplication (including 12 fetuses and 2 cases of pediatric patients) out of 5,188 subjects who sought genetic consultation at our hospital and received CMA detection. WES technology was subsequently utilized to identify additional sequence variants in a patient with multiple clinical anomalies.

Results

All 14 cases exhibited isolated recurrent 4q35.2 microduplications spanning a 1.0-Mb region encompassing the ZFP42 gene. Among the 12 fetuses, 11 displayed normal clinical features, while one was born with renal duplication and hydronephrosis. Additionally, in the two pediatric patients, WES was performed for Case 1, who presented with congenital cataracts, severe intellectual disability, and seizures. This patient inherited the 4q35.2 microduplication from his phenotypically normal mother. WES identified a novel NM_000276:c.2042G > T (p.G681V) variant in the OCRL gene, which is associated with Lowe syndrome and may account for the observed phenotypic variability within this family.

Conclusion

A series of 14 cases with isolated recurrent 4q35.2 microduplications were investigated, highlighting a potential association with increased susceptibility to renal abnormalities. Further, the present findings may expand the mutation spectrum of the OCRL gene associated with Lowe syndrome and provide valuable insights for the genetic etiological diagnosis of patients with unexplained copy number variants.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12884-024-06818-z.

Keywords

Whole exome sequencing
Chromosomal microarray analysis
Phenotypical diversity
4q35.2 microduplication
Lowe syndrome
Quanzhou City Science and Technology Project of China2023NS068 2024NY070 Huaqiao University Joint of Hospital and University Innovation Project2023YX001 issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmcIntroduction

Partial trisomy 4q is a relatively rare syndrome. The first documented case of this condition was reported in 1971 by Hoehn et al. [1]. The clinical features of partial 4q microduplication syndrome are typically characterized by developmental delay, intellectual disability, microcephaly, facial dysmorphism, congenital heart defects and renal malformations [2–4]. Notably, there is a scarcity of research on pure 4q35.2 microduplication at present. A previous study conducted by Zaki et al. [5] reported bilateral calcification of basal ganglia in a patient with duplication of both 11q13.1q22.1 and 4q35.2. This finding suggests that the 4q35.2 microduplication may contribute to susceptibility to basal ganglia calcification. At the same time, a recent study conducted by Bogs et al. [6] indicated that duplication or triplication of 4q35.2 may increase susceptibility to the development of renal, ear, and diaphragmatic anomalies. Nevertheless, the recurrent 4q35.2 microduplication encompassing a 1.0-Mb segment that includes the ZFP42 gene is classified as a variant of uncertain significance (VOUS). Currently, there are no studies linking the ZEP42 gene specifically to a particular disease.

As chromosomal microarray analysis (CMA) technology advances and becomes more widely utilized, the identification of VOUS is likely to increase [7–9]. In addition, whole exome sequencing (WES) technology has also been employed in revealing the phenotypical variability of VOUS, including the variants of Xp22.31, 1q12.1 and 16p11.2 microdeletions/microduplications [10–12]. However, to date, there has been no study investigating the genetic etiology of 4q35.2 microduplications with variable phenotypes.

The aim of the present study was to investigate the genotype-phenotype correlations of isolated recurrent 1.0-Mb 4q35.2 microduplications in 14 cases within the Chinese population. Moreover, WES was employed to identify supplementary sequence variants in a patient with recurrent 4q35.2 microduplication, who displayed phenotypic variability within the family.

Materials and methods

Subjects

The present study encompassed a total of 5,014 prenatal amniotic fluid samples and 174 peripheral blood samples from individuals who underwent CMA from September 2017 to April 2023 at Quanzhou Women’s and Children’s Hospital, China. Among the described individuals, 14 unrelated subjects who harbored isolated recurrent 4q35.2 microduplication were enrolled, including 12 fetuses and two pediatric patients. Additionally, one pediatric patient with congenital cataracts, severe intellectual disability and seizures was further subject to WES detection. Informed consent was obtained from all the subjects. The study protocol was approved by the Ethics Committee of the aforementioned hospital (2020 No.12).

Karyotype analysis

Approximately 30 ml of amniotic fluid or 2 ml of peripheral blood was collected from pregnant women or pediatric patients for karyotype analysis. Chromosomes were prepared using the Sinochrome Chromprep II automatic chromosome harvesting system (Shanghai Lechen Biotechnology Co., Ltd.) following the karyotype operation procedure established by the Prenatal Diagnosis Department of our hospital [13, 14]. Nomenclature and diagnosis of the karyotypes were performed according to the International System for Human Cytogenomic Nomenclature (ISCN 2020).

Chromosomal microarray analysis

The QIAamp DNA blood Kit (QIAGEN, Germany) was used for DNA extraction from amniotic fluid and peripheral blood in the samples. SNP array detection was performed using the AffymetrixCytoScan™ 750 K chip according to the Affymetrix CytoScan Assay User Guide (http://www.thermofisher.com), as described previously [14]. To assess the genome-wide variation in each sample, Chromosome Analysis Suite (ChAS) v4.0 software was used to analyze the fluorescence signals. Copy number variants were interpreted using databases such as DGV, OMIM, DECIPHER, and PubMed. These variants were classified as pathogenic, likely pathogenic, VOUS, likely benign, or benign according to the guidelines of the American College of Medical Genetics and Genomics (ACMG) [15].

Whole exome sequencing and data analysis

The extracted DNA was further subjected to WES analysis. DNA quantification was performed using the Qubit dsDNA HS Assay (Invitrogen, Carlsbad, CA, USA). Approximate mean fragment length of 150–200 bp was sheared using the Covaris LE220 (Covaris, Woburn, MA, USA). Sheared DNA was used for library preparation of targeted regions by means of the SureSelect whole-exome capture kit (Agilent). The Illumina DNA Standards and Primer Premix Kit (Kapa Biosystems, Boston, MA, USA) was subsequently used for the quantification of sequencing libraries. Paired-end libraries were sequenced using the Illumina NovaSeq 6000 platform (Illumina, San Diego, CA, USA) with 150 bp paired-end reads.

Data analysis encompassed variant calling, annotation, and screening. Minor allele frequencies for all known variants were queried using the dbSNP, 1000 Genomes Project, Exome Aggregation Consortium, and Exome Variant Server databases. To assess the potential pathogenicity of the detected mutations, the OMIM, ClinVar, Human Gene Mutation Database, and SwissVar databases were utilized. Additionally, SIFT, MutationTaster, PolyPhen2, PROVEAN, Human Splicing Finder, MetaSVM, GERP++_RS, and MaxEntScan were employed to predict the biological impact of amino acid substitutions or indels. Variants were classified according to the ACMG guidelines [16] as pathogenic, likely pathogenic, VOUS, likely benign or benign. Candidate variants were selected after combining the clinical information of proband and the aforementioned information, placing emphasis on de novo variants, compound heterozygote, homozygote and hemizygote. Sanger sequencing was performed for further verification of the variants detected using WES.

Results

Sample information

In the present study, a total of 14 unrelated subjects who harbored isolated recurrent 4q35.2 microduplication were enrolled, including 12 fetuses and two pediatric patients. As detailed in Table 1, among the 12 pregnancies included in the present study, only one case (Case 4) showed structural ultrasound anomalies, specifically renal duplication and hydronephrosis. Five other cases exhibited ultrasonic soft markers, while the remaining six cases had normal ultrasound findings but presented with other high-risk factors, including advanced maternal age, a history of poor pregnancy outcomes, high-risk results from non-invasive prenatal testing, or serological prenatal screening. Moreover, two pediatric patients were enrolled, in Case 1 several clinical features, including developmental delay, intellectual disability, congenital cataracts, short stature, and other congenital abnormalities were observed. Case 2 displayed clinical features including uterus duplex, unilateral renal agenesis, and mild intellectual disability.

Table 1 Results of karyotype and chromosomal microarray analysis of the enrolled subjects

Cases	Specimen	Ultrasound findings	Karyotype	CMA	Origin	Follow-up results	
Case 1	PB	/	46,XY	arr[GRCh37] 4q35.2(187,912,524_188,944,075)x3,1.0 Mb	Maternal	Global developmental delay, severe intellectual disability, congenital cataract, seizures, short stature	
Case 2	PB	/	46,XX	arr[GRCh37] 4q35.2(187,933,402_188,944,075)x3,1.0 Mb	/	Uterus duplex and unilateral renal agenesis, mild intellectual disability	
Case 3	AF	Increased nuchal translucency	46,XN	arr[GRCh37] 4q35.2(187,929,331_188,943,890)x3,1.0 Mb	Maternal	Born with normal phenotype	
Case 4	AF	Fetal left renal duplication and hydronephrosis	46,XN	arr[GRCh37] 4q35.2(187,900,881_188,943,890)x3,1.0 Mb	/	Born with left renal duplication and hydronephrosis	
Case 5	AF	Fetal hyperechoic bowel	46,XN	arr[GRCh37] 4q35.2(187,929,331_188,943,890)x3,1.0 Mb	/	Born with normal phenotype	
Case 6	AF	Normal	46,XN	arr[GRCh37] 4q35.2(187,907,094_188,943,890)x3,1.0 Mb	Paternal	Born with normal phenotype	
Case 7	AF	Normal	46,XN	arr[GRCh37] 4q35.2(187,912,583_188,943,890)x3,1.0 Mb	Paternal	Born with normal phenotype	
Case 8	AF	Normal	46,XN	arr[GRCh37] 4q35.2(187,907,095_188,943,890)x3,1.0 Mb	/	Born with normal phenotype	
Case 9	AF	Nasal bone absence/hypoplasia	46,XN	arr[GRCh37] 4q35.2(187,929,332_188,938,377)x3,1.0 Mb	/	Born with normal phenotype	
Case 10	AF	Normal	46,XN	arr[GRCh37] 4q35.2(187,929,332_188,943,890)x3,1.0 Mb	/	Born with normal phenotype	
Case 11	AF	Fetal hyperechoic bowel and renal pelvis dilation	46,XN	arr[GRCh37] 4q35.2(187,929,332_188,943,890)x3,1.0 Mb	/	Born with normal phenotype	
Case 12	AF	Normal	46,XN	arr[GRCh37] 4q35.2(187,933,402_188,943890)x4,1.0 Mb	/	Born with normal phenotype	
Case 13	AF	Normal	46,XN	arr[GRCh37] 4q35.2(187,933,402_188,943,890)x3,1.0 Mb	/	Born with normal phenotype	
Case 14	AF	Fetal cardiac hyperechogenicity, hyperechoic bowel and renal pelvis dilation	46,XN	arr[GRCh37] 4q35.2(187,942,663_188,943,890)x3,1.0 Mb	/	Born with normal phenotype	
PB: peripheral blood, AF: amniotic fluid, CMA: chromosomal microarray analysis

Karyotype analysis results

Among the enrolled 14 cases with isolated recurrent 4q35.2 microduplication, karyotype analysis did not reveal any obvious chromosomal abnormalities.

Chromosomal microarray analysis results

A recurrent 1.0-Mb 4q35.2 microduplication encompassing the ZFP42 gene was identified in all 14 enrolled cases. According to the Database of Genomic Variants, some CNVs that include the 4q35.2 microduplication were also detected in the present study [17, 18]. The DECIPHER database revealed that some cases with similar duplication fragments exhibited clinical phenotypes such as intellectual disability, language developmental delay, autism, and short stature (DECIPHER ID: 411617, VOUS; 300341, VOUS; 285401, VOUS; 294172, VOUS; 272963, /). Meanwhile, other cases containing the ZFP42 gene were interpreted as likely benign/benign in the database (DECIPHER ID: 288944, 287945, 270613. 289815, 290193). According to the ACMG guidelines, these recurrent 4q35.2 microduplications observed in the study were interpreted as VOUS.

In addition, parental CNV verification was conducted in four cases. Among these cases, two CNVs were inherited from the fathers, and two were inherited from the mothers. Notably, all parents exhibited normal clinical features.

Whole exome sequencing detection results

WES was conducted to further investigate a pediatric patient with isolated recurrent 4q35.2 microduplication and multiple abnormal features. As shown in Fig. 1, a novel hemizygous variant of NM_000276: c.2042G > T(p.G681V) in the OCRL gene on the X chromosome was observed in Case 1, which was inherited from his mother and further verified by Sanger sequencing (Fig. 1D). No frequency was reported in the databases of dbSNP, 1000 genomes, gnomAD, Clinvar, ExAC and PubMed. Moreover, several prediction software tools, namely Polyphen2_HDIV (1.0), Polyphen2_HVAR (1.0), MutationTaster (1.0), PROVEAN (-8.59), MetaSVM (0.181), SIFT (0.002) and GERP++_RS (6.16), indicated that the novel variant was harmful. As indicated in the InterPro database, the p.G681V variant is located in the RhoGAP domain of the OCRL protein (https://www.ebi.ac.uk/interpro/). Structural simulations of the OCRL protein revealed that, in the wild-type protein, the glycine at position 681 forms hydrogen bonds with threonine at position 644. Yet, in the mutant protein with valine at position 681, these bonds are instead formed with cysteine at position 679, potentially altering the tertiary structure of the OCRL protein (Fig. 2). The OCRL gene variant was classified as a VOUS (PM2_supporting, PP3, PP4), according to the ACMG guidelines. Unfortunately, Case 2 and Case 4, who also presented with clinical abnormalities, declined to undergo further WES detection.

Fig. 1 Recurrent 4q35.2 microduplication and OCRL gene variant detected in family 1 using CMA, WES and Sanger sequencing. (A): A 1.0-Mb microduplication in 4q35.2 region was observed in the proband of family 1 using CMA. (B): The WES detection results also demonstrated the 4q35.2 microduplication in the patient. (C): A novel hemizygous variant of c.2042G > T (p.G681V) in OCRL gene on the X chromosome was identified in the proband by means of WES. (D): The OCRL gene variant detected by WES was verified by means of Sanger sequencing in the proband. The parental verification results elicited that the hemizygous variant in OCRL gene in the proband was inherited from his mother. In addition, Sanger sequencing demonstrated that the OCRL gene variant was not present in the proband’s sister

Fig. 2 Three-dimensional structures prediction of the c.2042G > T (p.G681V) variant in OCRL gene. (A): In the wild-type OCRL protein, the glycine at position 681 forms hydrogen bonds with threonine at position 644. (B): In the mutant OCRL protein, where glycine at position 681 is substituted with valine, hydrogen bonds are formed with cysteine at position 679

Pregnancy outcome follow-up results

Further follow-up on pregnancy outcomes revealed that all 12 fetuses with isolated recurrent 1.0 Mb 4q35.2 microduplication continued their pregnancies. As shown in Tables 1 and 11 fetuses were born with normal appearances and exhibited normal clinical features during six-month follow-up assessments. However, in Case 4, the fetus was born with left renal duplication and hydronephrosis, consistent with the prenatal ultrasound findings. A surgical procedure was performed to remove the duplicated left kidney shortly after birth. Currently, no additional clinical anomalies have been observed in this case.

Discussion

To the present knowledge, there are fewer than 10 clinical studies available in the literature on 4q35.2 microduplication, with research specifically focusing on isolated 4q35.2 microduplication being even more limited [5, 6, 19]. The phenotypical diversity associated with 4q35.2 microduplication has been documented in prior research and various databases. Nonetheless, the presence of unexplained variable features adds complexity to clinical consultations and highlights the need for further research and investigation in order to better understand and manage this condition. WES has emerged as a valuable technology for identifying the genetic etiology of uncertain CNVs [10–13]. The sequence variants detected through WES may provide insights into the clinical variability observed in patients with unexplained CNVs [20]. In the present study, 14 cases of isolated recurrent 4q35.2 microduplication with 1.0-Mb segment containing the ZFP42 gene were presented in a Chinese cohort. These cases also exhibited variable phenotypes. In addition, WES technology was conducted to find additional sequence variants which may be responsible for the variable clinical phenotypes observed in patients with isolated recurrent 4q35.2 microduplication.

In the present study, two pediatric patients with isolated recurrent 4q35.2 microduplication were identified, both of whom exhibited multiple clinical abnormalities that could not be fully explained by the 4q35.2 microduplication alone. Consequently, WES was performed for Case 1. A novel hemizygous variant of c.2042G > T in OCRL gene was identified in Case 1. The OCRL gene, located on chromosome X, consists of 23 exons and encodes a phosphatidylinositol 4,5-bisphosphate-5-phosphatase that acts on phosphoinositides [21]. Pathogenic mutations in OCRL gene would lead to Lowe syndrome, a rare X-linked recessive hereditary disease, which is characterized by congenital cataracts, central hypotonia, intellectual disability and renal Fanconi syndrome [22]. Congenital cataracts have consistently been observed in male patients, most of whom also exhibit varying degrees of intellectual disability, with some individuals experiencing seizures, as reported in the literature [23–26]. Further, in a prior retrospective study involving 12 male patients with Lowe syndrome, short stature and developmental delay were observed in all patients, and seizures occurred in 50% of the patients [23]. In Case 1 of the present study, congenital cataracts, developmental delay, severe intellectual disability, short stature and seizures were also observed, aligning with the clinical phenotypes of Lowe syndrome. The belief of the present authors is that the variant of c.2042G > T in the OCRL gene may account for the severe clinical features observed in Case 1, who harbored an isolated recurrent 4q35.2 microduplication.

In the present study, 12 fetuses with isolated recurrent 4q35.2 microduplication were also enrolled, six of them had normal prenatal ultrasound examination results. Notably, renal duplication and hydronephrosis were observed in Case 4. Additionally, renal developmental anomaly of unilateral renal agenesis was also observed in pediatric patient of Case 2. Moreover, Case 11 and Case 14 also presented with an ultrasonic soft marker anomaly of renal pelvis dilation. Given the clinical findings in individuals with 4q35.2 microduplication, renal developmental abnormalities may be associated with the microduplication. Notably, a previous study by Bogs et al. [6] reported a 3.73–4.43 Mb 4q35.2 triplication in a patient with congenital heart defects, unilateral renal agenesis, and ear anomalies, suggesting that 4q35.2 duplications or triplications may be susceptibility factors for renal abnormalities. As such, the belief of the present authors is that the renal abnormality observed in the present study could be ascribed to 4q35.2 microduplication.

An overview of the present findings indicates that most individuals with recurrent 4q35.2 microduplication may present with a normal clinical phenotype. Further research is needed to gather additional functional evidence regarding the OCRL variants detected in our cases that are linked to Lowe syndrome. Moreover, additional scientific studies are required to establish clear phenotype-genotype correlations between renal developmental abnormalities and the 4q35.2 microduplication.

In conclusion, 14 cases of isolated recurrent 1.0-Mb 4q35.2 microduplication in the Chinese population were investigated, providing valuable information for understanding the genotype and phenotype correlations. The belief of the present authors is that the isolated recurrent 4q35.2 microduplication may result in normal or mild clinical features, but may increase susceptibility to renal abnormalities. In addition, the present findings revealed a novel variant in the OCRL gene causing Lowe syndrome, which may broaden the mutation spectrum of Lowe syndrome. The present study further underscores the value of WES technology in diagnosing the etiology of unexplained CNVs with phenotypical variability.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Acknowledgements

Appreciation is extended to the Huaqiao University and the Quanzhou Science and Technology Bureau for their funding support of this work. Gratitude is also expressed to the patients and their guardians for their participation in the study.

Author contributions

JZ wrote the article; SZ, QW and YJ recruited the participants and performed clinical consultation; SZ was responsible for the karyotype analysis and data analysis; HL performed bioinformatics analysis; NZ, CC and JZ revised and polished the paper. All authors have approved the final version of the article.

Funding

This research was Sponsored by Huaqiao University Joint of Hospital and University Innovation Project (2023YX001) and Quanzhou City Science and Technology Project of China (2023NS068 and 2024NY070).

Data availability

Data is provided within the manuscript or supplementary information files.

Declarations

Ethics approval and consent to participate

Ethics Committee approval was obtained from the Institutional Ethics Committee of Quanzhou Women’s and Children’s Hospital for the commencement of this study (2022No.46). Informed consent was obtained from all study participants, who agreed to the publication of the study report. All procedures involving human participants adhered to the ethical standards of the institutional and/or national research committees and were in accordance with the 1964 Helsinki Declaration and its subsequent amendments or comparable ethical standards.

Consent for publication

Written informed consent was obtained from the parents of the patients for the publication of their genetic data and relevant information, including that of their children. The written informed consent is available upon request.

Competing interests

The authors declare no conflict of interest.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Hoehn H Sander C Sander LZ Aneusomie De Recombinaison: rearrangement between paternal chromosomes 4 and 18 yielding offspring with features of the 18q- syndrome Ann Genet 1971 14 3 187 92 5315465
Hoehn H, Sander C, Sander LZ. Aneusomie De Recombinaison: rearrangement between paternal chromosomes 4 and 18 yielding offspring with features of the 18q- syndrome. Ann Genet. 1971;14(3):187–92.5315465
2. Cakmak-Genc G Karakas-Celik S Dursun A Piskin İE Partial trisomy 4q and partial monosomy 9p in a girl with choanal atresia and various dysmorphic findings Gene 2015 568 2 211 4 10.1016/j.gene.2015.05.022 25979671
Cakmak-Genc G, Karakas-Celik S, Dursun A, Piskin İE. Partial trisomy 4q and partial monosomy 9p in a girl with choanal atresia and various dysmorphic findings. Gene. 2015;568(2):211–4.25979671
3. Zhuang J Zhang N Fu W Cytogenetic and molecular analysis of distal 4q duplication with distinctive phenotype using single-nucleotide polymorphism array Mol Cytogenet 2021 14 1 46 10.1186/s13039-021-00568-9 34587985
Zhuang J, Zhang N, Fu W, et al. Cytogenetic and molecular analysis of distal 4q duplication with distinctive phenotype using single-nucleotide polymorphism array. Mol Cytogenet. 2021;14(1):46.34587985
4. Rinaldi R De Bernardo C Assumma M Cytogenetic and molecular characterization of a de novo 4q24qter duplication and correlation to the associated phenotype Am J Med Genet A 2003 118A 2 122 6 10.1002/ajmg.a.10093 12655492
Rinaldi R, De Bernardo C, Assumma M, et al. Cytogenetic and molecular characterization of a de novo 4q24qter duplication and correlation to the associated phenotype. Am J Med Genet A. 2003;118A(2):122–6.12655492
5. Zaki MS Eid OM Eid MM Bilateral calcification of basal ganglia in a patient with duplication of both 11q13.1q22.1 and 4q35.2 with new phenotypic features Cytogenet Genome Res 2019 159 3 130 6 10.1159/000504075 31715598
Zaki MS, Eid OM, Eid MM, et al. Bilateral calcification of basal ganglia in a patient with duplication of both 11q13.1q22.1 and 4q35.2 with new phenotypic features. Cytogenet Genome Res. 2019;159(3):130–6.31715598
6. Bogs T Kipfmüller F Kohlschmidt N Gembruch U Müller A Reutter H Familial tetrasomy 4q35.2 associated with congenital diaphragmatic hernia and unilateral renal agenesis: a case report J Med Case Rep 2016 10 76 10.1186/s13256-016-0855-1 27036947
Bogs T, Kipfmüller F, Kohlschmidt N, Gembruch U, Müller A, Reutter H. Familial tetrasomy 4q35.2 associated with congenital diaphragmatic hernia and unilateral renal agenesis: a case report. J Med Case Rep. 2016;10:76.27036947
7. Retterer K Juusola J Cho MT Clinical application of whole-exome sequencing across clinical indications Genet Med 2016 18 7 696 704 10.1038/gim.2015.148 26633542
Retterer K, Juusola J, Cho MT, et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med. 2016;18(7):696–704.26633542
8. Petrovski S Aggarwal V Giordano JL Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study Lancet 2019 393 10173 758 67 10.1016/S0140-6736(18)32042-7 30712878
Petrovski S, Aggarwal V, Giordano JL, et al. Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study. Lancet. 2019;393(10173):758–67.30712878
9. Lata S, Marasa M, Li Y et al. Whole-Exome Sequencing in Adults With Chronic Kidney Disease: A Pilot Study [published correction appears in Ann Intern Med. 2018;168(4):308]. Ann Intern Med. 2018;168(2):100–109.
10. Ying Q Hani B Flamingo T Exome sequencing identified a, de novo, mutation of, PURA, gene in a patient with familial Xp22.31 microduplication Eur J Med Genet 2019 62 2 103 8 10.1016/j.ejmg.2018.06.010 29908350
Ying Q, Hani B, Flamingo T, et al. Exome sequencing identified a, de novo, mutation of, PURA, gene in a patient with familial Xp22.31 microduplication. Eur J Med Genet. 2019;62(2):103–8.29908350
11. Qiao Y Badduke C Tang F Whole exome sequencing of families with 1q21.1 microdeletion or microduplication Am J Med Genet A 2017 173 7 1782 91 10.1002/ajmg.a.38247 28475290
Qiao Y, Badduke C, Tang F, et al. Whole exome sequencing of families with 1q21.1 microdeletion or microduplication. Am J Med Genet A. 2017;173(7):1782–91.28475290
12. Dastan J Chijiwa C Tang F Exome sequencing identifies pathogenic variants of VPS13B in a patient with familial 16p11.2 duplication BMC Med Genet 2016 17 1 78 10.1186/s12881-016-0340-0 27832746
Dastan J, Chijiwa C, Tang F, et al. Exome sequencing identifies pathogenic variants of VPS13B in a patient with familial 16p11.2 duplication. BMC Med Genet. 2016;17(1):78.27832746
13. Zhuang J Wang Y Zeng S Lv C Lin Y Jiang Y A prenatal diagnosis and genetics study of five pedigrees in the Chinese population with Xp22.31 microduplication Mol Cytogenet 2019 12 50 10.1186/s13039-019-0461-1 31857824
Zhuang J, Wang Y, Zeng S, Lv C, Lin Y, Jiang Y. A prenatal diagnosis and genetics study of five pedigrees in the Chinese population with Xp22.31 microduplication. Mol Cytogenet. 2019;12:50.31857824
14. Zhuang J Chen C Jiang Y Application of the BACs-on-beads assay for the prenatal diagnosis of chromosomal abnormalities in Quanzhou, China BMC Pregnancy Childbirth 2021 21 1 94 10.1186/s12884-021-03589-9 33509128
Zhuang J, Chen C, Jiang Y, et al. Application of the BACs-on-beads assay for the prenatal diagnosis of chromosomal abnormalities in Quanzhou, China. BMC Pregnancy Childbirth. 2021;21(1):94.33509128
15. Riggs ER Andersen EF Cherry AM Correction: technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen) Genet Med 2021 23 11 2230 10.1038/s41436-021-01150-9 33731880
Riggs ER, Andersen EF, Cherry AM, et al. Correction: technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2021;23(11):2230.33731880
16. Richards S Aziz N Bale S Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology Genet Med 2015 17 5 405 24 10.1038/gim.2015.30 25741868
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.25741868
17. Shaikh TH Gai X Perin JC High-resolution mapping and analysis of copy number variations in the human genome: a data resource for clinical and research applications Genome Res 2009 19 9 1682 90 10.1101/gr.083501.108 19592680
Shaikh TH, Gai X, Perin JC, et al. High-resolution mapping and analysis of copy number variations in the human genome: a data resource for clinical and research applications. Genome Res. 2009;19(9):1682–90.19592680
18. Coe BP Witherspoon K Rosenfeld JA Refining analyses of copy number variation identifies specific genes associated with developmental delay Nat Genet 2014 46 10 1063 71 10.1038/ng.3092 25217958
Coe BP, Witherspoon K, Rosenfeld JA, et al. Refining analyses of copy number variation identifies specific genes associated with developmental delay. Nat Genet. 2014;46(10):1063–71.25217958
19. Sun L Wu Q Pei Y Prenatal diagnosis and genetic discoveries of an intracranial mixed neuronal-glial tumor: a case report and literature review Med (Baltim) 2016 95 45 e5378 10.1097/MD.0000000000005378
Sun L, Wu Q, Pei Y, et al. Prenatal diagnosis and genetic discoveries of an intracranial mixed neuronal-glial tumor: a case report and literature review. Med (Baltim). 2016;95(45):e5378.
20. Zhuang J Xie M Yao J A de novo PAK1 likely pathogenic variant and a de novo terminal 1q microdeletion in a Chinese girl with global developmental delay, severe intellectual disability, and seizures BMC Med Genomics 2023 16 1 3 10.1186/s12920-023-01433-x 36624491
Zhuang J, Xie M, Yao J, et al. A de novo PAK1 likely pathogenic variant and a de novo terminal 1q microdeletion in a Chinese girl with global developmental delay, severe intellectual disability, and seizures. BMC Med Genomics. 2023;16(1):3.36624491
21. Suchy SF Nussbaum RL The deficiency of PIP2 5-phosphatase in Lowe syndrome affects actin polymerization Am J Hum Genet 2002 71 6 1420 7 10.1086/344517 12428211
Suchy SF, Nussbaum RL. The deficiency of PIP2 5-phosphatase in Lowe syndrome affects actin polymerization. Am J Hum Genet. 2002;71(6):1420–7.12428211
22. De Matteis MA Staiano L Emma F Devuyst O The 5-phosphatase OCRL in Lowe syndrome and dent disease 2 Nat Rev Nephrol 2017 13 8 455 70 10.1038/nrneph.2017.83 28669993
De Matteis MA, Staiano L, Emma F, Devuyst O. The 5-phosphatase OCRL in Lowe syndrome and dent disease 2. Nat Rev Nephrol. 2017;13(8):455–70.28669993
23. Zheng B Chen Q Wang C Whole-genome sequencing revealed an interstitial deletion encompassing OCRL and SMARCA1 gene in a patient with Lowe syndrome Mol Genet Genomic Med 2019 7 9 e876 10.1002/mgg3.876 31376231
Zheng B, Chen Q, Wang C, et al. Whole-genome sequencing revealed an interstitial deletion encompassing OCRL and SMARCA1 gene in a patient with Lowe syndrome. Mol Genet Genomic Med. 2019;7(9):e876.31376231
24. Bökenkamp A Ludwig M The oculocerebrorenal syndrome of Lowe: an update Pediatr Nephrol 2016 31 12 2201 12 10.1007/s00467-016-3343-3 27011217
Bökenkamp A, Ludwig M. The oculocerebrorenal syndrome of Lowe: an update. Pediatr Nephrol. 2016;31(12):2201–12.27011217
25. Mongardi L Mantovani G Scerrati A De Bonis P Cavallo MA Epilepsy and cranial hemangioma in Lowe syndrome Acta Neurol Belg 2020 120 5 1199 200 10.1007/s13760-019-01162-y 31190138
Mongardi L, Mantovani G, Scerrati A, De Bonis P, Cavallo MA. Epilepsy and cranial hemangioma in Lowe syndrome. Acta Neurol Belg. 2020;120(5):1199–200.31190138
26. Pueschel SM Brem AS Nittoli P Central nervous system and renal investigations in patients with Lowe syndrome Childs Nerv Syst 1992 8 1 45 8 10.1007/BF00316562 1576608
Pueschel SM, Brem AS, Nittoli P. Central nervous system and renal investigations in patients with Lowe syndrome. Childs Nerv Syst. 1992;8(1):45–8.1576608
